My Favourite Stock Sitting Just Outside The ASX 200
Despite a stellar track record of growing earnings, cashflow, and dividends, this tailwind stock hasn’t yet joined the S&P ASX 200.
Despite a stellar track record of growing earnings, cashflow, and dividends, this tailwind stock hasn’t yet joined the S&P ASX 200.
Pexa Group (ASX: PXA) owns one of the most attractive businesses on the ASX, but the Pexa share price is in a slump.
As they are trading well below their 52 week highs, each of these stocks may tempt their shareholders to sell too cheap, to minimise tax.
Why has Supply Network performed so much better than Maxiparts?
Would you sell Best And Less (ASX: BST) shares to Brett Blundy and Ray Itaoui at $1.89?
DGL Group (ASX: DGL) shares have dropped a long way from the highs, and arguably DGL Group shares are now quite cheap.
During 2022 it onboarded 89 new direct transacting partners including 7 distributors, and 819 new indirect transacting partners.
With losses, negative free cash flow, and debt, Service Stream stock combines multiple risk factors into one stinky sandwich.
Xero (ASX: XRO) shares rise after the FY 2023 Xero result demonstrates increasing focus on profitability and free cash flow.
ASX listed Insurance brokers AUB Group (ASX: AUB), Steadfast Group (ASX: SDF) and PSC Insurance (ASX: PSI) have been strong performing stocks.
On a basic human level, a guidance upgrade signals “things are better than we thought they were”, so upgrades are worth noticing.
We like to take note when a small cap company upgrades profit guidance and today Vysarn (ASX: VYS) lifted profit guidance by more than 20%.
ASX small cap stock Probiotec (ASX: PBP) looks like it offers growth at a reasonable price.
The Mader Group share price has had a strong run lately, but does the valuation make sense?
Propel Funeral Partners (ASX: PFP) could be considered a lower risk ASX stock, because increasing demand can be confidently forecast.
DUG Technology (ASX: DUG) and Fineos (ASX: FCL) have certainly submitted improved numbers this quarterly reporting season.
NHS strikes are taking a toll on Alcidion’s sales cycle.
Korvest (ASX: KOV) is a low P/E stock with strong recent results, but does competition make business too difficult?
Close The Loop (ASX: CLG) is clearly good to the environment, but will the ASX stock be good to shareholders?
Both these stocks have disappointed over the long term, but are showing stronger results recently.